Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 2 (2005), Issue 1 (January)

1. Cerebellar agenesis and diabetes insipidus.
   Neuropediatrics, 35(6): 364-7. [Abstract] [Full-text]
2. Effects of advanced glycation end products on hyaluronan photolysis: a new mechanism of diabetic vitreopathy.
   Ophthalmic Res, 36(6): 327-31. [Abstract] [Full-text]
3. Fixation stability and macular light sensitivity in patients with diabetic maculopathy: a microperimetric study with a scanning laser ophthalmoscope.
   Ophthalmologica, 219(1): 16-20. [Abstract] [Full-text]
4. Diabetes mellitus as a risk factor for glaucomatous optic neuropathy.
   Ophthalmologica, 219(1): 1-10. [Abstract] [Full-text]
5. Diabetes mellitus in cats.
   Vet Clin North Am Small Anim Pract, 35(1): 211-24. [Abstract] [Full-text]
6. Congenital nasal pyriform aperture stenosis with semilobar holoprosencephaly.
   Int J Pediatr Otorhinolaryngol, 69(1): 93-6. [Abstract] [Full-text]
7. NOD mice have a severely impaired ability to recruit leukocytes into sites of inflammation.
   Eur J Immunol, 35(1): 225-35. [Abstract] [Full-text]
8. Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirin.
   Thromb Haemost, 93(1): 8-16. [Abstract] [Full-text]
9. SDF-1 is both necessary and sufficient to promote proliferative retinopathy.
   J Clin Invest, 115(1): 86-93. [Abstract] [Full-text]
10. Gestational diabetes is associated with depressed adiponectin levels.
    J Soc Gynecol Investig, 12(1): 41-5. [Abstract] [Full-text]
11. Should we screen for occult coronary artery disease among asymptomatic patients with diabetes?
    J Am Coll Cardiol, 45(1): 50-3. [Abstract] [Full-text]
12. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging.
    J Am Coll Cardiol, 45(1): 43-9. [Abstract] [Full-text]
13. Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide.
    Am J Ophthalmol, 138(6): 970-7. [Abstract] [Full-text]
14. Effects of propolis on blood glucose, blood lipid and free radicals in rats with diabetes mellitus.
    Pharmacol Res, 51(2): 147-52. [Abstract] [Full-text]
15. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas.
    Pharmacol Res, 51(2): 117-23. [Abstract] [Full-text]
16. Effect of bosentan (ETA/ETB receptor antagonist) on metabolic changes during stress and diabetes.
    Pharmacol Res, 51(2): 107-15. [Abstract] [Full-text]
17. Glutamate decarboxylase-derived IDDM autoantigens displayed on self-assembled protein nanoparticles.
    Biochem Biophys Res Commun, 327(2): 604-8. [Abstract] [Full-text]
18. Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes.
    Am Heart J, 148(6): 1034-40. [Abstract] [Full-text]
19. How does the prognosis of diabetes compare with that of established vascular disease? Insights from the Canadian Vascular Protection (VP) Registry.
    Am Heart J, 148(6): 1028-33. [Abstract] [Full-text]
20. Direct stenting compared to conventional stenting in Diabetic Patients Undergoing Elective Angioplasty for Coronary Artery Disease (DECIDE): a multicenter, open label, randomized, controlled efficacy study.
    Am Heart J, 148(6): 1007-11. [Abstract] [Full-text]
21. Diabetes and risk of prostate cancer in a prospective cohort of US men.
    Am J Epidemiol, 161(2): 147-52. [Abstract] [Full-text]
22. Microalbuminuria as a screening tool in cystic fibrosis-related diabetes.
    Pediatr Pulmonol, 39(2): 103-7. [Abstract] [Full-text]
23. Cancer, type 2 diabetes, and ageing: news from flies and worms.
    Swiss Med Wkly, 134(49): 711-9. [Abstract] [Full-text]
24. Quality of life and diabetes knowledge of young persons with type 1 diabetes: Influence of treatment modalities and demographics.
    J Am Diet Assoc, 105(1): 85-91. [Abstract] [Full-text]
25. Insulin resistance in human adipocytes occurs downstream of IRS1 after surgical cell isolation but at the level of phosphorylation of IRS1 in type 2 diabetes.
    FEBS J, 272(1): 141-51. [Abstract] [Full-text]
26. (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
    J Med Chem, 48(1): 141-51. [Abstract] [Full-text]
27. Adenoviral overexpression of interleukin-1 receptor antagonist protein increases beta-cell replication in rat pancreatic islets.
    Gene Ther, 12(2): 120-8. [Abstract] [Full-text]
28. A new challenge in pediatric obesity: pediatric hyperglycemic hyperosmolar syndrome.
    Pediatr Crit Care Med, 6(1): 20-4. [Abstract] [Full-text]
29. Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes.
    Postgrad Med J, 81(951): 1-6. [Abstract] [Full-text]
30. Insulin, C-peptide, and restenosis after femoral artery balloon angioplasty in type II diabetic and nondiabetic patients.
    J Vasc Interv Radiol, 16(1): 31-5. [Abstract] [Full-text]
31. Results of a randomized, double-blind, placebo-controlled study administering glimepiride to patients with type 2 diabetes mellitus inadequately controlled with rosiglitazone monotherapy.
    Clin Ther, 26(11): 1783-90. [Abstract] [Full-text]
32. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.
    Clin Ther, 26(11): 1714-27. [Abstract] [Full-text]
33. AT1 receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic rats.
    Cardiovasc Res, 65(2): 374-86. [Abstract] [Full-text]
34. The D allele of the ACE I/D common gene variant is associated with Type 2 diabetes mellitus in Caucasian subjects.
    Mol Genet Metab, 84(1): 83-9. [Abstract] [Full-text]
35. The impact of acute elevation of non-esterified fatty acids on insulin sensitivity and secretion in women with former gestational diabetes.
    Clin Endocrinol (Oxf), 62(1): 79-84. [Abstract] [Full-text]
36. Impaired circulating glucagon-like peptide-1 response to oral glucose in women with previous gestational diabetes.
    Clin Endocrinol (Oxf), 62(1): 51-5. [Abstract] [Full-text]
37. Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension.
    Eur J Clin Invest, 35(1): 8-12. [Abstract] [Full-text]
38. Phlorizin: a review.
    Diabetes Metab Res Rev, 21(1): 31-8. [Abstract] [Full-text]
39. Somatostatin receptors and autoimmune-mediated diabetes.
    Diabetes Metab Res Rev, 21(1): 15-30. [Abstract] [Full-text]
40. Susceptible and protective human leukocyte antigen class II alleles and haplotypes in bahraini type 2 (non-insulin-dependent) diabetes mellitus patients.
    Clin Diagn Lab Immunol, 12(1): 213-7. [Abstract] [Full-text]
41. APOE epsilon4 is not a susceptibility gene in idiopathic or diabetic sensory neuropathy.
    Neurology, 64(1): 139-41. [Abstract] [Full-text]
42. Hypoglycaemic activity of Gentiana olivieri and isolation of the active constituent through bioassay-directed fractionation techniques.
    Life Sci, 76(11): 1223-38. [Abstract] [Full-text]
43. Self-perceived health and self-care among diabetic subjects with defective vision: a comparison between subjects with threat of blindness and blind subjects.
    J Diabetes Complications, 19(1): 54-9. [Abstract] [Full-text]
44. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening.
    J Diabetes Complications, 19(1): 47-53. [Abstract] [Full-text]
45. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
    J Diabetes Complications, 19(1): 42-6. [Abstract] [Full-text]
46. Ten-year incidence of self-reported erectile dysfunction in people with long-term type 1 diabetes.
    J Diabetes Complications, 19(1): 35-41. [Abstract] [Full-text]
47. Considerable disturbances of cardiovascular risk factors in women with diabetes and myocardial infarction.
    J Diabetes Complications, 19(1): 26-34. [Abstract] [Full-text]
48. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
    J Diabetes Complications, 19(1): 18-25. [Abstract] [Full-text]
49. Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes: a prospective study of 1662 episodes.
    J Diabetes Complications, 19(1): 10-7. [Abstract] [Full-text]
50. The Family Investigation of Nephropathy and Diabetes (FIND): design and methods.
    J Diabetes Complications, 19(1): 1-9. [Abstract] [Full-text]
51. Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart.
    Clin Biochem, 38(2): 191-6. [Abstract] [Full-text]
52. Combination treatment of vitamin C and desferrioxamine suppresses glomerular superoxide and prostaglandin E production in diabetic rats.
    Diabetes Obes Metab, 7(1): 106-9. [Abstract] [Full-text]
53. Increased adiposity and reduced adipose tissue mRNA expression of uncoupling protein-2 in first-degree relatives of type 2 diabetic patients: evidence for insulin stimulation of UCP-2 and UCP-3 gene expression in adipose tissue.
    Diabetes Obes Metab, 7(1): 98-105. [Abstract] [Full-text]
54. Efficacy and safety of ezetimibe co-administered with simvastatin in thiazolidinedione-treated type 2 diabetic patients.
    Diabetes Obes Metab, 7(1): 88-97. [Abstract] [Full-text]
55. Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin.
    Diabetes Obes Metab, 7(1): 73-82. [Abstract] [Full-text]
56. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes.
    Diabetes Obes Metab, 7(1): 56-64. [Abstract] [Full-text]
57. Effects of agar (kanten) diet on obese patients with impaired glucose tolerance and type 2 diabetes.
    Diabetes Obes Metab, 7(1): 40-6. [Abstract] [Full-text]
58. Efficacy, dose-response relationship and safety of once-daily extended-release metformin (Glucophage XR) in type 2 diabetic patients with inadequate glycaemic control despite prior treatment with diet and exercise: results from two double-blind, placebo-controlled studies.
    Diabetes Obes Metab, 7(1): 28-39. [Abstract] [Full-text]
59. Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR.
    J Clin Periodontol, 32(1): 40-4. [Abstract] [Full-text]
60. Misunderstandings about illness and treatment among patients with type 2 diabetes.
    J Adv Nurs, 49(2): 146-54. [Abstract] [Full-text]
61. Systematic review of hyperbaric oxygen in the management of chronic wounds.
    Br J Surg, 92(1): 24-32. [Abstract] [Full-text]
62. The role of myocardial perfusion imaging in special populations: women, diabetics, and heart failure.
    Semin Nucl Med, 35(1): 52-61. [Abstract] [Full-text]
63. Permanent neonatal diabetes in an Asian infant.
    J Pediatr, 146(1): 131-3. [Abstract] [Full-text]
64. Preventing foot ulcers in patients with diabetes.
    JAMA, 293(2): 217-28. [Abstract] [Full-text]
65. Fasting serum glucose level and cancer risk in Korean men and women.
    JAMA, 293(2): 194-202. [Abstract] [Full-text]
66. Elective cesarean section to prevent anal incontinence and brachial plexus injuries associated with macrosomia--a decision analysis.
    Int Urogynecol J Pelvic Floor Dysfunct, 16(1): 19-28; discussion 28. [Abstract] [Full-text]
67. Case-control single-marker and haplotypic association analysis of pedigree data.
    Genet Epidemiol, 28(2): 110-22. [Abstract] [Full-text]
68. Lipid peroxidation in diabetes mellitus.
    Antioxid Redox Signal, 7(1): 256-68. [Abstract] [Full-text]
69. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes.
    J Epidemiol Community Health, 59(2): 134-9. [Abstract] [Full-text]
70. Prevalence and prognostic significance of asymptomatic peripheral arterial disease in 68-year-old men with diabetes. Results from the population study 'Men born in 1914' from Malmö, Sweden.
    Eur J Vasc Endovasc Surg, 29(2): 182-9. [Abstract] [Full-text]
71. Chorea and Broca aphasia induced by diabetic ketoacidosis in a type 1 diabetic patient diagnosed as Moyamoya disease.
    Diabetes Res Clin Pract, 67(2): 180-5. [Abstract] [Full-text]
72. The prevalence of diabetes mellitus and impaired fasting glucose/glycaemia (IFG) in suburban and rural Nepal-the communities--based cross-sectional study during the democratic movements in 1990.
    Diabetes Res Clin Pract, 67(2): 167-74. [Abstract] [Full-text]
73. Orthostatic hypotension predicts vascular death in older diabetic patients.
    Diabetes Res Clin Pract, 67(2): 163-6. [Abstract] [Full-text]
74. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.
    Diabetes Res Clin Pract, 67(2): 152-62. [Abstract] [Full-text]
75. The financial costs of hospital care for people with diabetes who have single and multiple macrovascular complications.
    Diabetes Res Clin Pract, 67(2): 144-51. [Abstract] [Full-text]
76. Plasma chloride concentration as a new diagnostic indicator of insulin insufficiency.
    Diabetes Res Clin Pract, 67(2): 137-43. [Abstract] [Full-text]
77. Factors related to exercise capacity in asymptomatic middle-aged type 2 diabetic patients.
    Diabetes Res Clin Pract, 67(2): 130-6. [Abstract] [Full-text]
78. Sense of coherence and power among people with blindness caused by diabetes.
    Diabetes Res Clin Pract, 67(2): 124-9. [Abstract] [Full-text]
79. Apoptosis and its pathway in early post-implantation embryos of diabetic rats.
    Diabetes Res Clin Pract, 67(2): 110-8. [Abstract] [Full-text]
80. 'Programming' of orexigenic and anorexigenic hypothalamic neurons in offspring of treated and untreated diabetic mother rats.
    Brain Res, 1031(2): 276-83. [Abstract] [Full-text]
81. Morphological changes in the rat endocrine pancreas within 12 h of intravenous streptozotocin administration.
    Anat Histol Embryol, 34(1): 42-7. [Abstract] [Full-text]
82. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia.
    Cell Tissue Res, 319(2): 231-42. [Abstract] [Full-text]
83. Pathways for the bradykinin B1 receptor-mediated diabetic hyperalgesia in mice.
    Inflamm Res, 53(12): 653-7. [Abstract] [Full-text]
84. Calcitriol improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats.
    Calcif Tissue Int, 75(6): 526-32. [Abstract] [Full-text]
85. Study of global left atrial shortening in fetuses of diabetic mothers.
    Arq Bras Cardiol, 83(6): 473-5; 470-2. [Abstract] [Full-text]
86. Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study.
    J Neurol Neurosurg Psychiatry, 76(2): 240-5. [Abstract] [Full-text]
87. Insulin autoantibodies in cord blood from neonates with and without a sibling with type 1 diabetes--prevalence and characterization.
    Eur J Obstet Gynecol Reprod Biol, 118(2): 166-9. [Abstract] [Full-text]
88. Calpain-10 gene polymorphisms and type 2 diabetes in West Africans: the Africa America Diabetes Mellitus (AADM) Study.
    Ann Epidemiol, 15(2): 153-9. [Abstract] [Full-text]
89. Lay perceptions of type 2 diabetes in Scotland: bringing health services back in.
    Soc Sci Med, 60(7): 1423-35. [Abstract] [Full-text]
90. Ocular structure and function in an aged monkey with spontaneous diabetes mellitus.
    Exp Eye Res, 80(1): 37-42. [Abstract] [Full-text]
91. Antidiabetic activity of Caesalpinia bonducella F. in chronic type 2 diabetic model in Long-Evans rats and evaluation of insulin secretagogue property of its fractions on isolated islets.
    J Ethnopharmacol, 97(1): 117-22. [Abstract] [Full-text]
92. Antioxidant activity of Cassia fistula (Linn.) flowers in alloxan induced diabetic rats.
    J Ethnopharmacol, 97(1): 39-42. [Abstract] [Full-text]
93. The antidiabetic activity of the herbal preparation ADD-199 in mice: a comparative study with two oral hypoglycaemic drugs.
    J Ethnopharmacol, 97(1): 31-8. [Abstract] [Full-text]
94. GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes.
    Horm Metab Res, 36(11): 867-76. [Abstract] [Full-text]
95. GIP as a potential therapeutic agent?
    Horm Metab Res, 36(11): 859-66. [Abstract] [Full-text]
96. Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes.
    Horm Metab Res, 36(11): 852-8. [Abstract] [Full-text]
97. Beta- and alpha-cell dysfunction in type 2 diabetes.
    Horm Metab Res, 36(11): 775-81. [Abstract] [Full-text]
98. Oral antihyperglycemic therapy for type 2 diabetes mellitus.
    CMAJ, 172(2): 213-26. [Abstract] [Full-text]
99. The acute effects of insulin on the cardiorespiratory responses to hypoxia in streptozotocin-induced diabetic rats.
    Acta Physiol Scand, 183(1): 107-15. [Abstract] [Full-text]
100. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study.
     Am J Gastroenterol, 100(1): 48-55. [Abstract] [Full-text]
101. Muscle-specific Pten deletion protects against insulin resistance and diabetes.
     Mol Cell Biol, 25(3): 1135-45. [Abstract] [Full-text]
102. Melanotroph pituitary adenoma in a cat with diabetes mellitus.
     Vet Pathol, 42(1): 92-7. [Abstract] [Full-text]
103. The G-250A substitution in the promoter region of the hepatic lipase gene is associated with the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
     J Intern Med, 257(2): 185-93. [Abstract] [Full-text]
104. Differential effect of insulin and elevated glucose level on adenosine transport in rat B lymphocytes.
     Int Immunol, 17(2): 145-54. [Abstract] [Full-text]
105. Re-institution of good metabolic control in diabetic rats and activation of caspase-3 and nuclear transcriptional factor (NF-kappaB) in the retina.
     Acta Diabetol, 41(4): 194-9. [Abstract] [Full-text]
106. A pilot study of mitochondrial DNA point mutation A3243G in a sample of Croatian patients having type 2 diabetes mellitus associated with maternal inheritance.
     Acta Diabetol, 41(4): 179-84. [Abstract] [Full-text]
107. Effect of the pyridoindole antioxidant stobadine on sodium handling of renal Na,K-ATPase in rats with streptozotocin-induced diabetes.
     Acta Diabetol, 41(4): 172-8. [Abstract] [Full-text]
108. T-cell receptor repertoire and function in umbilical cord blood lymphocytes from newborns of type 1 diabetic mothers.
     Acta Diabetol, 41(4): 167-71. [Abstract] [Full-text]
109. Advanced glycation endproducts in peripheral nerve in type 2 diabetes with neuropathy.
     Acta Diabetol, 41(4): 158-66. [Abstract] [Full-text]
110. Is selective screening for gestational diabetes mellitus worthwhile everywhere?
     Acta Diabetol, 41(4): 154-7. [Abstract] [Full-text]
111. Sibutramine in the treatment of obesity in type 2 diabetic patients and in nondiabetic subjects.
     Acta Diabetol, 41(4): 146-53. [Abstract] [Full-text]
112. Scanning for MODY5 gene mutations in Chinese early onset or multiple affected diabetes pedigrees.
     Acta Diabetol, 41(4): 137-45. [Abstract] [Full-text]
113. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure.
     Am Heart J, 149(1): 168-74. [Abstract] [Full-text]
114. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
     Am Heart J, 149(1): 159-67. [Abstract] [Full-text]
115. Impact of physicians' beliefs and practices on cholesterol levels in patients with type 2 diabetes: a longitudinal assessment.
     Am Heart J, 149(1): 104-11. [Abstract] [Full-text]
116. The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design.
     Am Heart J, 149(1): 13-9. [Abstract] [Full-text]
117. Forearm vascular reactivity is differentially influenced by gliclazide and glibenclamide in chronically treated type 2 diabetic patients.
     Clin Physiol Funct Imaging, 25(1): 40-6. [Abstract] [Full-text]
118. Acute effects of monounsaturated fatty acids with and without omega-3 fatty acids on vascular reactivity in individuals with type 2 diabetes.
     Diabetologia, 48(1): 113-22. [Abstract] [Full-text]
119. Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice.
     Diabetologia, 48(1): 58-67. [Abstract] [Full-text]
120. A new test for autonomic cardiovascular and neuroendocrine responses in diabetes mellitus: evidence for early vagal dysfunction.
     Diabetologia, 48(1): 180-6. [Abstract] [Full-text]
121. Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria.
     Diabetologia, 48(1): 156-63. [Abstract] [Full-text]
122. Characterisation of subjects with early abnormalities of glucose tolerance in the Stockholm Diabetes Prevention Programme: the impact of sex and type 2 diabetes heredity.
     Diabetologia, 48(1): 35-40. [Abstract] [Full-text]
123. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus.
     Diabetologia, 48(1): 164-71. [Abstract] [Full-text]
124. The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes.
     Diabetologia, 48(1): 83-95. [Abstract] [Full-text]
125. Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy.
     Diabetologia, 48(1): 198-202. [Abstract] [Full-text]
126. Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy.
     Diabetologia, 48(1): 149-55. [Abstract] [Full-text]
127. The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
     Diabetologia, 48(1): 41-8. [Abstract] [Full-text]
128. Disparity of autonomic control in type 2 diabetes mellitus.
     Diabetologia, 48(1): 172-9. [Abstract] [Full-text]
129. Leisure time physical activity and the risk of type 2 diabetes in men and women from the general population. The MONICA/KORA Augsburg Cohort Study.
     Diabetologia, 48(1): 27-34. [Abstract] [Full-text]
130. Hormone-sensitive lipase is reduced in the adipose tissue of patients with type 2 diabetes mellitus: influence of IL-6 infusion.
     Diabetologia, 48(1): 105-12. [Abstract] [Full-text]
131. High frequency of abnormal glucose tolerance in DQA1*0102/DQB1*0602 relatives identified as part of the Diabetes Prevention Trial--Type 1 Diabetes.
     Diabetologia, 48(1): 68-74. [Abstract] [Full-text]
132. A matrix-assisted laser desorption/ionization mass spectrometry study of the non-enzymatic glycation products of human globins in diabetes.
     Rapid Commun Mass Spectrom, 19(2): 162-8. [Abstract] [Full-text]
133. Moderate exercise with a dietary vitamin C and e combination protects against streptozotocin-induced oxidative damage to the kidney and lens in pregnant rats.
     Exp Clin Endocrinol Diabetes, 113(1): 53-9. [Abstract] [Full-text]
134. Effect of pioglitazone on lipids in well controlled patients with diabetes mellitus type 2 -- results of a pilot study.
     Exp Clin Endocrinol Diabetes, 113(1): 49-52. [Abstract] [Full-text]
135. Gastric electrical stimulation results in improved metabolic control in diabetic patients suffering from gastroparesis.
     Exp Clin Endocrinol Diabetes, 113(1): 38-42. [Abstract] [Full-text]
136. High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats.
     Diabetologia, 47(12): 2235-46. [Abstract] [Full-text]
137. Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes.
     Diabetologia, 47(12): 2215-25. [Abstract] [Full-text]
138. Effects of lipase inhibition on gastric emptying of, and on the glycaemic, insulin and cardiovascular responses to, a high-fat/carbohydrate meal in type 2 diabetes.
     Diabetologia, 47(12): 2208-14. [Abstract] [Full-text]
139. Analysis of the contribution to type 2 diabetes susceptibility of sequence variation in the gene encoding stearoyl-CoA desaturase, a key regulator of lipid and carbohydrate metabolism.
     Diabetologia, 47(12): 2168-75. [Abstract] [Full-text]
140. Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study.
     Diabetologia, 47(12): 2152-9. [Abstract] [Full-text]
141. Coffee consumption and glucose tolerance status in middle-aged Japanese men.
     Diabetologia, 47(12): 2145-51. [Abstract] [Full-text]
142. Type 2 diabetes and risk of non-embolic ischaemic stroke in Japanese men and women.
     Diabetologia, 47(12): 2137-44. [Abstract] [Full-text]
143. Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes.
     Diabetologia, 47(12): 2129-36. [Abstract] [Full-text]
144. Antioxidative treatment prevents activation of death-receptor- and mitochondrion-dependent apoptosis in the hearts of diabetic rats.
     Diabetologia, 47(12): 2072-80. [Abstract] [Full-text]
145. Amputation as a marker of the quality of foot care in diabetes.
     Diabetologia, 47(12): 2051-8. [Abstract] [Full-text]
146. Mitochondrial dysfunction and type 2 diabetes.
     Science, 307(5708): 384-7. [Abstract] [Full-text]
147. Type 2 diabetes-a matter of beta-cell life and death?
     Science, 307(5708): 380-4. [Abstract] [Full-text]
148. Diabetes, obesity, and the brain.
     Science, 307(5708): 375-9. [Abstract] [Full-text]
149. How obesity causes diabetes: not a tall tale.
     Science, 307(5708): 373-5. [Abstract] [Full-text]
150. Genetic factors in type 2 diabetes: the end of the beginning?
     Science, 307(5708): 370-3. [Abstract] [Full-text]
151. High CSF-insulin in violent suicide attempters.
     Psychiatry Res, 129(3): 249-55. [Abstract] [Full-text]
152. The acute effects of glycemic control on nerve conduction in human diabetics.
     Clin Neurophysiol, 116(2): 270-4. [Abstract] [Full-text]
153. Strength-duration properties and glycemic control in human diabetic motor nerves.
     Clin Neurophysiol, 116(2): 254-8. [Abstract] [Full-text]
154. Reactive oxygen species mediate abnormal contractile response to sympathetic nerve stimulation and noradrenaline in the vas deferens of chronically diabetic rats: effects of in vivo treatment with antioxidants.
     Fundam Clin Pharmacol, 19(1): 73-9. [Abstract] [Full-text]
155. Improved diabetes control by using 'close adjustment algorithms'.
     Pediatr Int, 46(6): 678-84. [Abstract] [Full-text]
156. Near patient blood ketone measurements and their utility in predicting diabetic ketoacidosis.
     Diabet Med, 22(2): 221-4. [Abstract] [Full-text]
157. 'Disappearing diabetes'--resolution of apparent Type 1 diabetes in a patient with AIDS and cytomegalovirus (CMV) infection.
     Diabet Med, 22(2): 218-20. [Abstract] [Full-text]
158. Glycaemic and insulin responses of six traditional Sudanese carbohydrate-rich meals in subjects with Type 2 diabetes mellitus.
     Diabet Med, 22(2): 213-7. [Abstract] [Full-text]
159. Controlling the diabetes epidemic: how should we screen for undiagnosed diabetes and dysglycaemia?
     Diabet Med, 22(2): 207-12. [Abstract] [Full-text]
160. Parental age at delivery, birth order, birth weight and gestational age are associated with the risk of childhood Type 1 diabetes: a UK regional retrospective cohort study.
     Diabet Med, 22(2): 200-6. [Abstract] [Full-text]
161. Interclinician variation in diabetes foot assessment--a national lottery?
     Diabet Med, 22(2): 196-9. [Abstract] [Full-text]
162. NT-proBNP in normoalbuminuric patients with Type 2 diabetes mellitus.
     Diabet Med, 22(2): 188-95. [Abstract] [Full-text]
163. Unchanged incidence of diabetic nephropathy in Type 1 diabetes: a nation-wide study in Iceland.
     Diabet Med, 22(2): 182-7. [Abstract] [Full-text]
164. In-hospital breast feeding rates among women with gestational diabetes and pregestational Type 2 diabetes in South Auckland.
     Diabet Med, 22(2): 177-81. [Abstract] [Full-text]
165. Healing diabetic neuropathic foot ulcers: are we getting better?
     Diabet Med, 22(2): 172-6. [Abstract] [Full-text]
166. Predicting vascular risk in Type 1 diabetes: stratification in a hospital based population in Scotland.
     Diabet Med, 22(2): 164-71. [Abstract] [Full-text]
167. Effects of nateglinide on myocardial microvascular reactivity in Type 2 diabetes mellitus--a randomized study using positron emission tomography.
     Diabet Med, 22(2): 158-63. [Abstract] [Full-text]
168. Psychiatric morbidity and health outcome in Type 1 diabetes--perspectives from a prospective longitudinal study.
     Diabet Med, 22(2): 152-7. [Abstract] [Full-text]
169. Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the 'accelerator hypothesis' (2).
     Diabet Med, 22(2): 144-51. [Abstract] [Full-text]
170. Clinical characteristics, beta-cell function, HLA class II and mutations in MODY genes in non-paediatric subjects with Type 1 diabetes without pancreatic autoantibodies.
     Diabet Med, 22(2): 137-43. [Abstract] [Full-text]
171. Creation of a multidisciplinary, evidence based, clinical guideline for the assessment, investigation and management of acute diabetes related foot complications.
     Diabet Med, 22(2): 127-36. [Abstract] [Full-text]
172. Insulin treatment and cardiovascular disease; friend or foe? A point of view.
     Diabet Med, 22(2): 118-26. [Abstract] [Full-text]
173. G protein polymorphisms in hypertension, atherosclerosis, and diabetes.
     Annu Rev Med, 56: 17-28. [Abstract] [Full-text]
174. Effect of type 2 diabetes on various electrophoretic characteristics of low-density lipoprotein particles in women.
     Diabetologia, 47(12): 2114-7. [Abstract] [Full-text]
175. Neonatal diabetes, with hypoplastic pancreas, intestinal atresia and gall bladder hypoplasia: search for the aetiology of a new autosomal recessive syndrome.
     Diabetologia, 47(12): 2160-7. [Abstract] [Full-text]
176. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.
     Diabetologia, 47(12): 2176-84. [Abstract] [Full-text]
177. Postprandial hypotension treated with acarbose in a patient with type 1 diabetes mellitus.
     Clin Auton Res, 14(6): 405-7. [Abstract] [Full-text]
178. Distal site testing of sympathetic skin response (big toe) in diabetic polyneuropathy.
     Clin Auton Res, 14(6): 401-4. [Abstract] [Full-text]
179. Report from the CDC. The National Public Health Initiative on Diabetes and Women's Health: leading the way for women with and at risk for diabetes.
     J Womens Health (Larchmt), 13(9): 962-7. [Abstract] [Full-text]
180. Exaggerated relative nasal-temporal asymmetry of macular capillary blood flow in patients with clinically significant diabetic macular oedema.
     Br J Ophthalmol, 89(2): 142-6. [Abstract] [Full-text]
181. Pubertal stage and hypoglycaemia counterregulation in type 1 diabetes.
     Arch Dis Child, 90(2): 190-4. [Abstract] [Full-text]
182. Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-beta.
     Cardiovasc Res, 65(3): 694-701. [Abstract] [Full-text]
183. Transient expression of hypoxia-inducible factor-1 alpha and target genes in peripheral nerves from diabetic rats.
     Neurosci Lett, 374(3): 179-82. [Abstract] [Full-text]
184. Extended DR3-D6S273-HLA-B haplotypes are associated with increased susceptibility to type 1 diabetes in US Caucasians.
     Tissue Antigens, 65(1): 115-9. [Abstract] [Full-text]
185. Testing for statistical discrimination in health care.
     Health Serv Res, 40(1): 227-52. [Abstract] [Full-text]
186. Acanthosis nigricans in a plaque of scleredema on the back of a diabetic patient: a case report.
     Int J Dermatol, 44(1): 45-7. [Abstract] [Full-text]
187. Non-convulsive status epilepticus and consciousness disturbance after star fruit (Averrhoa carambola) ingestion in a dialysis patient.
     Nephrology (Carlton), 9(6): 362-5. [Abstract] [Full-text]
188. Concentration of cord serum placenta growth factor in normal and diabetic pregnancies.
     BJOG, 112(1): 75-9. [Abstract] [Full-text]
189. Systematic reviews of epidemiology in diabetes: finding the evidence.
     BMC Med Res Methodol, 5(1): 2. [Abstract] [Full-text]
190. Midlife cardiovascular risk factors and risk of dementia in late life.
     Neurology, 64(2): 277-81. [Abstract] [Full-text]
191. Long-term treatment with nifedipine modulates procoagulant marker and C-C chemokine in hypertensive patients with type 2 diabetes mellitus.
     Thromb Res, 115(4): 277-85. [Abstract] [Full-text]
192. Is postprandial hypertriglyceridaemia in relatives of type 2 diabetic subjects a consequence of insulin resistance?
     Eur J Clin Invest, 35(2): 117-25. [Abstract] [Full-text]
193. Peroxisome proliferator-activated receptor gamma: the more the merrier?
     Eur J Clin Invest, 35(2): 82-92; discussion 80. [Abstract] [Full-text]
194. Aberrant regulation of interleukin-12 receptor beta2 chain on type 1 cytokine-stimulated T lymphocytes in type 1 diabetes.
     Immunology, 114(2): 287-93. [Abstract] [Full-text]
195. Glycation of CD59 impairs complement regulation on erythrocytes from diabetic subjects.
     Immunology, 114(2): 280-6. [Abstract] [Full-text]
196. Lymphocyte sub-populations in gestational diabetes.
     Am J Reprod Immunol, 53(1): 21-9. [Abstract] [Full-text]
197. Obsessive-compulsive symptoms in adults with history of rheumatic fever, Sydenham's chorea and type I diabetes mellitus: preliminary results.
     Acta Psychiatr Scand, 111(2): 159-61. [Abstract] [Full-text]
198. Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice.
     J Am Soc Nephrol, 16(2): 363-73. [Abstract] [Full-text]
199. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study.
     J Am Soc Nephrol, 16(2): 529-38. [Abstract] [Full-text]
200. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease.
     J Am Soc Nephrol, 16(2): 459-66. [Abstract] [Full-text]
201. Ala45Thr polymorphism of the NEUROD1 gene and diabetes susceptibility: a meta-analysis.
     Hum Genet, 116(3): 192-9. [Abstract] [Full-text]
202. Current status of the E23K Kir6.2 polymorphism: implications for type-2 diabetes.
     Hum Genet, 116(3): 133-45. [Abstract] [Full-text]
203. Effects of insulin-dependent diabetes mellitus on perforator-based flaps in streptozotocin diabetic rats.
     J Reconstr Microsurg, 21(1): 51-6. [Abstract] [Full-text]
204. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome.
     Am J Obstet Gynecol, 192(1): 134-9. [Abstract] [Full-text]
205. Retinal artery and vein diameters during pregnancy in diabetic women.
     Invest Ophthalmol Vis Sci, 46(2): 709-13. [Abstract] [Full-text]
206. Dietary patterns and the incidence of type 2 diabetes.
     Am J Epidemiol, 161(3): 219-27. [Abstract] [Full-text]
207. Reversal of experimental diabetes by multiple bone marrow transplantation.
     Biochem Biophys Res Commun, 328(1): 318-25. [Abstract] [Full-text]
208. Effects of galnon, a non-peptide galanin-receptor agonist, on insulin release from rat pancreatic islets.
     Biochem Biophys Res Commun, 328(1): 213-20. [Abstract] [Full-text]
209. Susceptibility to streptozotocin-induced diabetes is mapped to mouse chromosome 11.
     Biochem Biophys Res Commun, 328(1): 158-64. [Abstract] [Full-text]
210. Mucormycosis: a devastating fungal infection in diabetics.
     J Coll Physicians Surg Pak, 15(1): 43-5. [Abstract] [Full-text]
211. An implantable subcutaneous glucose sensor array in ketosis-prone rats: closed loop glycemic control.
     Artif Organs, 29(2): 131-43. [Abstract] [Full-text]
212. Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study.
     Clin Endocrinol (Oxf), 62(2): 137-44. [Abstract] [Full-text]
213. Mapping and association studies of diabetes related genes in the pig.
     Anim Genet, 36(1): 36-42. [Abstract] [Full-text]
214. Incidence and progression of diabetic retinopathy in an Aboriginal Australian population: results from the Katherine Region Diabetic Retinopathy Study (KRDRS). Report no. 2.
     Clin Experiment Ophthalmol, 33(1): 26-33. [Abstract] [Full-text]
215. Relationship between caloric intake and pregnancy outcome in diet-treated gestational diabetes mellitus.
     Nurs Health Sci, 7(1): 15-20. [Abstract] [Full-text]
216. Metabolic control, self-management and psychosocial adjustment in women with type 2 diabetes.
     J Clin Nurs, 14(2): 195-203. [Abstract] [Full-text]
217. Poor prognosis in proteinuric type 2 diabetic patients with retinopathy: insights from the RENAAL study.
     QJM, 98(2): 119-26. [Abstract] [Full-text]
218. Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US.
     Radiology, 234(2): 617-24. [Abstract] [Full-text]
219. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
220. 'Human' insulin versus animal insulin in people with diabetes mellitus.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
221. Patient education for preventing diabetic foot ulceration.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
222. Complementary and alternative medicine use among a multiethnic sample of older adults with diabetes.
     J Altern Complement Med, 10(6): 1061-6. [Abstract] [Full-text]
223. Vascular risk factors and diabetic neuropathy.
     N Engl J Med, 352(4): 341-50. [Abstract] [Full-text]
224. Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice.
     Antimicrob Agents Chemother, 49(2): 830-2. [Abstract] [Full-text]
225. Self-reported goals of older patients with type 2 diabetes mellitus.
     J Am Geriatr Soc, 53(2): 306-11. [Abstract] [Full-text]
226. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation.
     Kidney Int, 67(2): 714-20. [Abstract] [Full-text]
227. Effects of sulfonylureas, alpha-endosulfine counterparts, on glomerulosclerosis in type 1 and type 2 models of diabetes.
     Kidney Int, 67(2): 554-65. [Abstract] [Full-text]
228. Translation, cultural adaptation, initial reliability, and validation of Turkish 15D's version: a generic health-related quality of life (HRQoL) instrument.
     Eval Health Prof, 28(1): 53-66. [Abstract] [Full-text]
229. The influence of guidelines on the use of statins: analysis of prescribing trends 1998-2002.
     Br J Clin Pharmacol, 59(2): 227-32. [Abstract] [Full-text]
230. Effects of diabetes and CETP expression on diet-induced atherosclerosis in LDL receptor-deficient mice.
     APMIS, 113(1): 37-44. [Abstract] [Full-text]
231. Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections.
     J Antimicrob Chemother, 55(2): 240-5. [Abstract] [Full-text]
232. Effects of angiotensin type-1 receptor antagonism on small artery function in patients with type 2 diabetes mellitus.
     Hypertension, 45(2): 264-9. [Abstract] [Full-text]
233. Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes.
     Diabetes, 54(2): 306-10. [Abstract] [Full-text]
234. Comparative study of oral versus subcutaneous B:9-23 insulin peptide in Balb/c mice as an experimental model for autoimmune diabetes.
     Ann N Y Acad Sci, 1029: 331-3. [Abstract] [Full-text]
235. Differential immune induction with subcutaneous versus oral administration of a diabetogenic insulin peptide in the NOD mouse.
     Ann N Y Acad Sci, 1029: 328-30. [Abstract] [Full-text]
236. Oral insulin therapy to prevent progression of immune-mediated (type 1) diabetes.
     Ann N Y Acad Sci, 1029: 260-77. [Abstract] [Full-text]
237. Treatment with AT(1) receptor blocker restores diabetes-induced alterations in intracellular Ca(2+) transients and contractile function of rat myocardium.
     Arch Biochem Biophys, 435(1): 166-74. [Abstract] [Full-text]
238. Absence of diabetic hyperalgesia in bradykinin B1 receptor-knockout mice.
     Regul Pept, 127(1): 245-8. [Abstract] [Full-text]
239. Involvement of hypothalamic neuropeptide Y in regulating the amphetamine-induced appetite suppression in streptozotocin diabetic rats.
     Regul Pept, 127(1): 19-26. [Abstract] [Full-text]
240. Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease.
     J Surg Res, 123(2): 176-81. [Abstract] [Full-text]
241. Oral magnesium administration prevents vascular complications in STZ-diabetic rats.
     Life Sci, 76(13): 1455-64. [Abstract] [Full-text]
242. Relaxatory effect of magnesium on mesenteric vascular beds differs from normal and streptozotocin induced diabetic rats.
     Eur J Pharmacol, 508(1): 177-81. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.